Post-Market Registry to Evaluate the Safety and Efficacy of the The SUPRAFLEX CRUZâ„¢ Sirolimus Eluting Coronary Stent System in the Treatment of an Octo- and Nonagenerian All-Comer Patient Cohort With Coronary Artery Disease - the Cruz Senior Study